T cells, mast cells and microvascular density in diffuse large B cell lymphoma

Area of Science:

• Oncology
• Immunology
• Pathology

Background:

• Diffuse large B cell lymphoma (DLBCL) is the most prevalent type of non-Hodgkin lymphoma (NHL), comprising approximately 40% of all NHL cases.
• Tumor-associated inflammatory cells, specifically T cells and mast cells, play a role in promoting tumor angiogenesis.

Purpose of the Study:

• To investigate the expression of CD3 (a T cell marker) and tryptase (a mast cell marker) in DLBCL.
• To determine the relationship between CD3 expression, tryptase expression, and microvascular density (MVD) in DLBCL.
• To assess the significance of CD3 expression in relation to disease bulk (bulky vs. non-bulky).

Main Methods:

• Immunohistochemical analysis of CD3 and tryptase expression in DLBCL patient samples.
• Quantification of microvascular density (MVD) using established methods.
• Statistical analysis, including correlation and multiple regression, to evaluate relationships between markers and MVD, and differences based on disease bulk.

Main Results:

• CD3 expression was significantly lower in patients with bulky DLBCL compared to those with non-bulky disease.
• A positive correlation was observed between CD3 expression, tryptase expression, and MVD.
• Multiple regression analysis indicated that CD3 and tryptase effectively predicted MVD, suggesting their combined role in angiogenesis.

Conclusions:

• CD3 expression levels may serve as a potential indicator differentiating between bulky and non-bulky DLBCL.
• A complex interplay exists between T cells (CD3+), mast cells (tryptase+), and microvascular density, collectively contributing to tumor angiogenesis in DLBCL.
• These findings highlight the importance of the tumor microenvironment in DLBCL pathogenesis and suggest potential therapeutic targets related to angiogenesis.